Prognostic factors in crizotinib (CRZ)-resistant anaplastic lymphoma kinase (ALK+) non-small cell lung cancer (NSCLC) patients (Pts)

Annals of Oncology ◽

10.1093/annonc/mdx091.025 ◽

2017 ◽

Vol 28 ◽

pp. ii38-ii39

Author(s):

K.L. Reckamp ◽

J. Lee ◽

J. Huang ◽

I. Proskorovsky ◽

W. Reichmann ◽

...

Keyword(s):

Lung Cancer ◽

Prognostic Factors ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Small Cell Lung ◽

Anaplastic Lymphoma ◽

Download Full-text

Visual Effects in Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Treated with Crizotinib

Annals of Oncology ◽

10.1016/s0923-7534(20)32041-x ◽

2012 ◽

Vol 23 ◽

pp. xi44

Author(s):

P.-C. Yang ◽

R. Salgia ◽

B. Solomon ◽

A.T. Shaw ◽

D.R. Camidge ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Small Cell Lung ◽

Visual Effects ◽

Anaplastic Lymphoma ◽

Alk Positive ◽

Download Full-text

Regional reporting of the incidence of Anaplastic Lymphoma Kinase (ALK) mutation in 379 non-small-cell lung cancer (NSCLC) patients from Kolkata (Eastern India): Using IHC as the diagnostic modality in a considerable subset

Lung Cancer ◽

10.1016/s0169-5002(18)30033-3 ◽

2018 ◽

Vol 115 ◽

pp. S3

Author(s):

K. Chatterjee ◽

R. Bhowmik ◽

B. Chattopadhyay

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Eastern India ◽

Small Cell Lung ◽

Diagnostic Modality ◽

Anaplastic Lymphoma ◽

Download Full-text

PD.1.03 Ensartinib in Anaplastic Lymphoma Kinase (ALK) Positive Non-Small Cell Lung Cancer (NSCLC) Patients: Updated Data

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2018.07.028 ◽

2018 ◽

Vol 13 (9) ◽

pp. S156

Author(s):

T. Leal ◽

H. Wakelee ◽

K. Reckamp ◽

S. Waqar ◽

S. Patel ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Small Cell Lung ◽

Anaplastic Lymphoma ◽

Alk Positive ◽

Download Full-text

Cost-Effective Study of Alectinib in Treating Crizotinib-Failed Anaplastic Lymphoma Kinase Positive (ALK+) Non-Small Cell Lung Cancer (NSCLC) Patients in Taiwan

Value in Health ◽

10.1016/j.jval.2018.04.217 ◽

2018 ◽

Vol 21 ◽

pp. S34

Author(s):

C Liao ◽

C Wang ◽

KA Chan ◽

F Hsiao

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Cost Effective ◽

Small Cell Lung ◽

Anaplastic Lymphoma ◽

Download Full-text

5P Targeted degradation of anaplastic lymphoma kinase by target degraducer in non-small cell lung cancer

Annals of Oncology ◽

10.1016/s0923-7534(21)00167-8 ◽

2016 ◽

Vol 27 ◽

pp. ix2

Author(s):

J.Y. Hwang ◽

C.-H. Park ◽

D.H. Lee ◽

C.H. Kang ◽

C.O. Lee ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Small Cell Lung ◽

Anaplastic Lymphoma

Download Full-text

Cost-Effectiveness Analysis Of Ceritinib And Alectinib Versus Crizotinib In The Treatment Of Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer

Cancer Management and Research ◽

10.2147/cmar.s223441 ◽

2019 ◽

Vol Volume 11 ◽

pp. 9195-9202 ◽

Author(s):

Maobai Liu ◽

Longfeng Zhang ◽

Qishu Huang ◽

Na Li ◽

Bin Zheng ◽

...

Keyword(s):

Lung Cancer ◽

Cost Effectiveness ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Cost Effectiveness Analysis ◽

Small Cell Lung ◽

Anaplastic Lymphoma ◽

Effectiveness Analysis

Download Full-text

Favorable response to crizotinib in three patients with echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase fusion-type oncogene-positive non-small cell lung cancer

Cancer Science ◽

10.1111/j.1349-7006.2011.01970.x ◽

2011 ◽

Vol 102 (8) ◽

pp. 1602-1604 ◽

Author(s):

Takashi Kijima ◽

Kengo Takeuchi ◽

Satoshi Tetsumoto ◽

Kazuki Shimada ◽

Ryo Takahashi ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Small Cell Lung ◽

Anaplastic Lymphoma ◽

Download Full-text

Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer

New England Journal of Medicine ◽

10.1056/nejmx110006 ◽

2011 ◽

Vol 364 (6) ◽

pp. 588-588

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Small Cell Lung ◽

Kinase Inhibition ◽

Anaplastic Lymphoma

Download Full-text

Re‐Evaluating Progression in an Era of Progress: A Review of First‐ and Second‐Line Treatment Options in Anaplastic Lymphoma Kinase‐Positive Non‐Small Cell Lung Cancer

The Oncologist ◽

10.1634/theoncologist.2015-0396 ◽

2016 ◽

Vol 21 (6) ◽

pp. 755-761 ◽

Author(s):

Emily H. Castellanos ◽

Leora Horn

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Treatment Options ◽

Line Treatment ◽

Second Line ◽

Small Cell Lung ◽

Anaplastic Lymphoma

Download Full-text

A Patient With Anaplastic Lymphoma Kinase–Positive Non–Small Cell Lung Cancer With Development of Leptomeningeal Carcinomatosis While on Targeted Treatment With Crizotinib

Journal of the National Comprehensive Cancer Network ◽

10.6004/jnccn.2013.0054 ◽

2013 ◽

Vol 11 (4) ◽

pp. 389-394 ◽

Author(s):

Jonathan W. Riess ◽

Seema Nagpal ◽

Joel W. Neal ◽

Heather A. Wakelee

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Leptomeningeal Carcinomatosis ◽

Targeted Treatment ◽

Small Cell Lung ◽

Anaplastic Lymphoma

Download Full-text